Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,400
Closed -$247K 138
2023
Q3
$247K Sell
2,400
-687
-22% -$74K 0.03% 77
2023
Q2
$356K Sell
3,087
-405
-12% -$46K 0.05% 71
2023
Q1
$372K Sell
3,492
-819
-19% -$88.4K 0.05% 75
2022
Q4
$478K Buy
4,311
+237
+6% +$24.2K 0.06% 61
2022
Q3
$351K Buy
4,074
+538
+15% +$48K 0.05% 73
2022
Q2
$322K Buy
3,536
+564
+19% +$50K 0.04% 78
2022
Q1
$244K Buy
2,972
+31
+1% +$2.44K 0.03% 87
2021
Q4
$225K Sell
2,941
-652
-18% -$51.9K 0.03% 134
2021
Q3
$270K Sell
3,593
-2,068
-37% -$157K 0.05% 86
2021
Q2
$440K Buy
5,661
+715
+14% +$53.2K 0.07% 96
2021
Q1
$364K Sell
4,946
-7,354
-60% -$542K 0.06% 88
2020
Q4
$960K Buy
12,300
+5,088
+71% +$389K 0.39% 60
2020
Q3
$571K Sell
7,212
-209
-3% -$16.4K 0.29% 83
2020
Q2
$548K Buy
+7,421
New +$559K 0.29% 74
2020
Q1
Sell
-20,657
Closed -$1.79M 120
2019
Q4
$1.79M Buy
+20,657
New +$1.7M 0.72% 29
2019
Q2
Sell
-27,733
Closed -$2.2M 123
2019
Q1
$2.2M Sell
27,733
-13,945
-33% -$1.04M 0.98% 16
2018
Q4
$3.04M Buy
+41,678
New +$2.94M 1.31% 17

Other funds holding MRK

Rock Creek Group's MRK Position: Q4 2023 in Review

Rock Creek Group sold out of Merck (MRK) in Q4 2023, closing a stake of 2,400 shares — an estimated $247K sold.

Rock Creek Group first reported a position in MRK in Q4 2018 and held it in 17 quarters. The position peaked at $3.04M in Q4 2018. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Rock Creek Group reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • Rock Creek Group sold 2,400 Merck shares in Q4 2023, an estimated $247K.
  • Rock Creek Group first reported a position in Merck in Q4 2018 and held it in 17 quarters.
  • Rock Creek Group's Merck position peaked at $3.04M in Q4 2018.
  • 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Rock Creek Group's 13F filing for Q4 2023, filed 13 Feb 2024.